Pulsed estradiol exposure has a limited ability to induce uterine proliferation in ovariectomised female Wistar rats

Molecular and Cellular Endocrinology

Volumn 230, Issue 1-2, 2005, Pages 7-15

  Diel, Patrick ^a   Laudenbach Leschowsky, Ute ^a   Friedel, Angelika ^a   Voss, Anika ^a   Roussel, Jérôme ^b  

^a Deutsche Sporthochschule Köln ^*  (Germany)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Estradiol; HRT; Proliferation; Pulsed; Uterus

Indexed keywords

CYCLINE; ESTRADIOL; MESSENGER RNA; PROGESTERONE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; MOLECULAR DYNAMICS; NONHUMAN; OVARIECTOMY; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; RAT; UTERUS;

ANIMALS; CELL PROLIFERATION; COMPLEMENT C3; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; OVARIECTOMY; POSTMENOPAUSE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; RECEPTORS, PROGESTERONE; UTERUS;

EID: 12344259772     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2004.11.007     Document Type: Article

References (26)

1. V. Beral Million Women Study Collaborators Breast cancer and hormon-replacement therapy in the Million Woman Study Lancet 362 2003 419 427
2. V. Cavailles, A. Gompel, M.C. Portois, S. Thenot, N. Mabon, and F. Vignon Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells J. Mol. Endocrinol. 28 2002 165 175
3. P.D. Delmas, L. Marianowski, C. Perez Ade, C. Ribot, B. Pornel, S. Palacios, and P. Lopes Prevention of postmenopausal bone loss by pulsed estrogen therapy: comparison with transdermal route Maturitas 48 2 2004 85 96
4. J.P. Devissaguet, N. Brion, O. Lhote, and P. Deloffre Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations Eur. J. Drug Metab. Pharmacokinet. 24 1999 265 271
5. M.W. Draper The role of selective estrogen receptor modulators (SERMs) in postmenopausal health Ann. N.Y. Acad. Sci. 997 2003 373 377
6. A. Gompel, C. Bergeron, M. Jondet, M. Dhont, M.J. Van der Mooren, K.S. Toth, N. Panay, and T. Von Holst Endometrial safety and tolerability of AERODIOL (R) (intranasal estradiol) for 1 year Maturitas 36 2000 209 215
7. G.A. Greendale, N.P. Lee, and E.R. Arriola The menopause Lancet 353 1999 571 580
8. M.J. Iatropoulos, and G.M. Williams Proliferation markers Exp. Toxicol. Pathol. 48 1996 175 181
9. P. Kenemans, A.R. Genazzani, S. Palacios, and H.P.G. Schneider Pulsed estrogen therapy selectively modulates tissue response: a hypothesis Gynecol. Endocrinol. 18 2004 159 164
10. B. Kerdelhue, and J. Jolette The influence of the route of administration of 17beta-estradiol, intravenous (pulsed) versus oral, upon DMBA-induced mammary tumour development in ovariectomised rats Breast Cancer Res. Treat. 73 2002 13 22
11. S.H. Li, H.L. Huang, and Y.H. Chen Ovarian steroid-regulated synthesis and secretion of complement C3 and factor B in mouse endometrium during the natural estrous cycle and pregnancy period Biol. Reprod. 66 2002 322 332
12. C. Longcope, S. Gorbach, B. Goldin, M. Woods, J. Dwyer, and J. Warram The metabolism of estradiol: oral compared to intravenous administration J. Steroid Biochem. 23 1985 1065 1070
13. P. Lopes, H.M. Merkus, J. Nauman, F. Bruschi, J.M. Foidart, and J. Calaf Randomized comparison of intranasal and transdermal estradiol Obstet. Gynecol. 96 2000 906 912
14. L. Mattsson, Cl. Christiansen, J.-C. Colau, S. Palacios, P. Kenemans, Ch Bergeron, O. Chevallier, Th. Von Holst, and K. Gangar Clinical equivalence of intranasal and oral 17-β-estradiol for postmenopausal symptoms Am. J. Obstet. Gynecol. 182 2000 545 552
15. K. Michaelsson, J.A. Baron, B.Y. Farahmand, O. Johnell, C. Magnusson, P.G. Persson, I. Persson, S. Ljunghall The Swedish Hip Fracture Study Group Hormone replacement therapy and risk of hip fracture: population based case-control study BMJ 316 1998 1858 1863
16. S. Palacios Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss Climacteric 5 2002 32 39
17. C. Pelissier, A. de Kervasdoue, V.T. Chuong, E.L. Maugis, F. de Mouillac, M.H. Breil, G. Moniot, G. Zeitoun-Lepvrier, M. Robin, and B. Rime Clinical evaluation, dose-finding and acceptability of AERODIOL, the pulsed estrogen therapy for treatment of climacteric symptoms Maturitas 37 2001 181 189
18. R.R. Reddel, and R.L. Sutherland Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro Cancer Res. 47 1987 5323 5329
19. L. Russell, G.S. Hicks, A.K. Low, J.M. Shepherd, and C.A. Brown Phytoestrogens: a viable option? Am. J. Med. Sci. 324 2002 185 188
20. J.F. Savouret, A. Bailly, M. Misrahi, C. Rauch, G. Redeuilh, A. Chauchereau, and E. Milgrom Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene EMBO J. 10 1991 1875 1883
21. T. Simoncini, L. Fornari, P. Mannella, G. Varone, A. Caruso, J.K. Liao, and A.R. Genazzani Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase Steroids 67 2002 935 939
22. J. Studd, B. Pornel, I. Marton, J. Bringer, C. Varin, Y. Tsouderos, C. Christiansen Aerodiol Study Group Efficacy and acceptability of intranasal 17 beta-estradiol for menopausal symptoms: randomised dose-response study Lancet 353 1999 1574 1578
23. H. Vermeirsch, W. Van Den Broeck, M. Coryn, and P. Simoens Immunolocalization of sex steroid hormone receptors in the canine uterine tube and their relation to sex steroid hormone concentrations Reprod. Fertil. Dev. 14 2002 241 250
24. T. Van Gorp, and P. Neven Endometrial safety of hormone replacement therapy: review of literature Maturitas 42 2 2002 93 104
25. D.P. Vik, P. Amiguet, G.J. Moffat, M. Fey, F. Amiguet-Barras, R.A. Wetsel, and B.F. Tack Structural features of the human C3 gene: intron/exon organization, transcriptional start site, and promoter region sequence Biochemistry 30 1991 1080 1085
26. T. Yasui, H. Uemura, M. Takikawa, and M. Irahara Hormone replacement therapy in postmenopausal women J. Med. Invest. 50 2003 136 145